🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

#SickleCellDisease impacts 5M+ globally, leading to excruciating pain crises & other complications. At Cellarity, we're working hard to provide hope to these patients & are celebrating #WorldSickleCellDay. Learn more: bit.ly/4evHPgc #HopeThroughProgress #ThroughThePain

Our CEO Fabrice Chouraqui is featured in STAT discussing how we're revolutionizing drug discovery by looking at the whole cell instead of a singular target using AI/ML. Learn more about our innovative work and vision for the future of health care! bit.ly/3XGsB1Z

Our CEO Fabrice Chouraqui spoke with Drug Target Review to explain how Cellarity is using #AI and #MachineLearning to predict and prevent drug toxicity, potentially reducing treatment costs. More: bit.ly/4cfeODT

Companies pioneering original science are essential to bring about new medicines. We are proud to be one with our Al/ML solution to repeatedly generate disease-modifying medicines against dysfunctional cellular biology as part of the #FlagshipFounded ecosystem.

We're thrilled to announce that we've appointed Percy Carter, MBA, Ph.D., to our Board of Directors! Dr. Carter's leadership will help accelerate our work to bring value to patients via novel biology and differentiated drug candidates. Welcome, Percy! bwnews.pr/3YpvOD8

Our CEO Fabrice Chouraqui explains the power of our drug discovery platform in a new interview with Pharmaceutical Executive. Listen here: bit.ly/3WegtTc

We’re focusing on the whole cell to transform drug discovery. Hear from our CEO Fabrice Chouraqui on Pharmaceutical Executive about our drug candidate with gene-therapy-like efficacy in a once-daily pill to treat sickle cell disease: bit.ly/4cO02UL

Our CEO Fabrice Chouraqui & The Medicine Maker discuss how Cellarity’s platform uses #AI and #ML to re-envision #DrugDiscovery & the impact approaches like ours could have on people living with disease and in need of new therapies. Read the Q&A: bit.ly/4cF3AYQ

Cellarity CEO Fabrice Chouraqui joins Biotech2050 Podcast's Rahul Chaturvedi to discuss his career journey, and the shared language and mindset of our teams working to harness #AI and #MachineLearning to bring innovative medicines to patients. 🎙️ Listen: open.spotify.com/episode/71uPMq…

Our CEO Fabrice Chouraqui tells Pharmaceutical Executive how our cutting-edge platform is transforming the treatment of MASH in partnership with Novo Nordisk. The future of medicine is here, and our platform is leading the way. Learn more: bit.ly/3WeCjpM

Introducing #medSCAI24! We’re bringing together the top minds in #AI and #MachineLearning to tackle barriers to using new technology to bring medicines to patients faster. Don’t miss keynote speaker Aviv Regev of Genentech. Join us: cellarity.com/symposium/ #BiggerLeaps

Our Chief Data Officer Parul Bordia Doshi joins the 🎙Data in Biotech podcast to explore how #AI & single-cell multiomics are transforming #DrugDiscovery. Listen to the episode: pod.co/data-in-biotec…

Attend #medSCAI24—our 3rd annual symposium on medicines, single cell tech & #AI! Join leaders for two sessions on AI & #MachineLearning-powered #DrugDiscovery. Featuring Arpeggio Biosciences, MIT Dept of BE, UW Genome Sciences, Novartis & more. Register ➡️ bit.ly/3yOdJEL

What do you want to discuss with or hear from leaders at the cutting edge of medicines, single cell and AI/machine learning at medSCAI 2024?

Thrilled to announce our #medSCAI24 panel on realizing AI's full translational impact on drug development. Register ➡️ bit.ly/3yOdJEL Ryan Cross the Science Boss, 1910 Genetics, NVIDIA, Novo Nordisk, Novartis

⏰ Only 8 days until #medSCAI24! Register for this symposium on the cutting edge of medicines, single cell and #AI and #MachineLearning. Secure your spot ➡️ bit.ly/3yOdJEL  #BiggerLeaps

In October, we welcomed industry peers for #medSCAI24 to share insights, collaborate & explore the future of #AI & #MachineLearning to foster advancements across industry & academia. We look forward to continuing the conversations sparked at this year’s event. #BiggerLeaps

Our Chief Medical Officer Cameron Trenor spoke with PharmaVoice to discuss challenges facing #SickleCell disease treatments and how Cellarity is approaching a new option for patients. 🔗More at bit.ly/3YZS3PY #SCD #BiggerLeaps

Cellarity is pleased to welcome Alec Reynolds as interim President, bringing 17+ years of drug development, strategy & partnering expertise from Celgene & Flagship Pioneering Medicines, where he is COO. Thank you, Fabrice Chouraqui, for your leadership. 🔗cellarity.com/about/?filter=…

Cellarity is pleased to welcome Ted Myles as Chief Executive Officer. For more: cellarity.com/news_item/ted-…